ASCEND BY NTHRYS
Research Abroad Products

Interactomics Project Topics

Browse all focused areas across all project categories under this field.

Showing 13–24 of 200 project topics
Multi-Modal Drug-Target Binding Affinity Prediction Engine
A proprietary computational service combining structural data, sequence information, and chemical properties to predict drug-target binding with high accuracy. Generates premium licensing revenue and accelerates lead compound identification for biotech and pharma clients.
Interactome Network Drug Design Platforms Click to view more details →
High-Throughput Interactome Screening and Hit Identification Platform
A software platform integrating yeast two-hybrid, co-immunoprecipitation, and mass spectrometry data processing to systematically identify novel drug targets from complex interaction networks. Monetizes through assay service offerings and per-sample analysis fees.
Interactome Network Drug Design Platforms Click to view more details →
Biomarker Discovery Through Network Pharmacology Analytics Suite
An advanced analytics platform that maps drug mechanisms of action through interactome perturbation analysis and predicts patient stratification biomarkers. Enables companion diagnostic development and precision medicine initiatives generating B2B licensing and data licensing revenue.
Interactome Network Drug Design Platforms Click to view more details →
Graph Neural Network Drug Repurposing and Polypharmacology Solver
A machine learning tool using graph neural networks to identify off-target interactions and novel therapeutic applications for existing drugs across disease indications. Creates recurring platform fees while reducing time-to-market for drug repurposing initiatives by 50%.
Interactome Network Drug Design Platforms Click to view more details →
Integrated Omics Interactome Data Management and Integration Platform
An enterprise data management solution consolidating proteomics, genomics, and functional interaction data into unified queryable knowledge bases for research institutions. Operates on white-label licensing and managed service models generating predictable annual recurring revenue.
Interactome Network Drug Design Platforms Click to view more details →
AI-Driven Adverse Event Prediction via Off-Target Interaction Analysis
A predictive platform using machine learning to identify potential safety liabilities by mapping unintended drug-protein interactions across biological networks. Delivers value through risk mitigation consulting, regulatory support, and licensing to pharmaceutical safety teams.
Interactome Network Drug Design Platforms Click to view more details →
Cellular Context-Aware Interactome Modeling and Simulation Engine
A computational platform that simulates dynamic protein interactions within specific cellular contexts using mechanistic modeling and cell-type-specific omics integration. Monetizes through enterprise licensing, research collaborations, and platform-as-a-service subscription tiers.
Interactome Network Drug Design Platforms Click to view more details →
Federated Learning Platform for Proprietary Interactome Data Monetization
A privacy-preserving platform enabling pharmaceutical companies to collaboratively train predictive models on proprietary interaction datasets without data exposure. Generates revenue through network participation fees, model licensing, and enhanced prediction accuracy as a premium service.
Interactome Network Drug Design Platforms Click to view more details →
High-Throughput Protein-Protein Interaction Screening Platform
SaaS platform enabling rapid identification of protein-protein interactions through automated yeast-two-hybrid, co-immunoprecipitation, and surface plasmon resonance assays. Delivers revenue through tiered subscription models, sample processing fees, and premium data analytics dashboards for pharmaceutical and biotech clients.
Protein Interaction Biomarker Discovery Services Click to view more details →
AI-Powered Biomarker Prediction Engine for Clinical Development
Machine learning software analyzing protein interactome data to predict patient response biomarkers and stratify clinical trial populations with unprecedented accuracy. Generates licensing fees, platform subscriptions, and risk-sharing partnerships with pharmaceutical companies seeking faster drug development timelines.
Protein Interaction Biomarker Discovery Services Click to view more details →
Post-Translational Modification Interaction Detection Service
Commercial laboratory service utilizing mass spectrometry and phosphoproteomics to map protein interactions altered by phosphorylation, ubiquitination, and glycosylation events. Monetizes through project-based service fees, recurring biomarker monitoring contracts, and data licensing to oncology and immunotherapy companies.
Protein Interaction Biomarker Discovery Services Click to view more details →
Spatial Proteomics Biomarker Mapping Software Suite
Integrated software platform processing imaging mass cytometry and multiplex immunofluorescence data to identify tissue-specific protein interaction signatures as diagnostic or prognostic biomarkers. Captures revenue through software licensing, imaging scan analysis fees, and enterprise contracts with clinical diagnostic labs.
Protein Interaction Biomarker Discovery Services Click to view more details →